3b2w: Difference between revisions
From Proteopedia
Jump to navigationJump to search
No edit summary |
No edit summary |
||
| Line 1: | Line 1: | ||
[[Image:3b2w.png|left|200px]] | [[Image:3b2w.png|left|200px]] | ||
{{STRUCTURE_3b2w| PDB=3b2w | SCENE= }} | {{STRUCTURE_3b2w| PDB=3b2w | SCENE= }} | ||
===Crystal structure of pyrimidine amide 11 bound to Lck=== | ===Crystal structure of pyrimidine amide 11 bound to Lck=== | ||
{{ABSTRACT_PUBMED_18083554}} | {{ABSTRACT_PUBMED_18083554}} | ||
== | ==About this Structure== | ||
[[3b2w]] is a 1 chain structure of [[Proto-oncogene tyrosine-protein kinase]] and [[Tyrosine kinase]] with sequence from [http://en.wikipedia.org/wiki/Homo_sapiens Homo sapiens]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=3B2W OCA]. | |||
== | ==See Also== | ||
*[[Proto-oncogene tyrosine-protein kinase|Proto-oncogene tyrosine-protein kinase]] | |||
*[[Tyrosine kinase|Tyrosine kinase]] | |||
==Reference== | ==Reference== | ||
<ref group="xtra">PMID: | <ref group="xtra">PMID:018083554</ref><references group="xtra"/> | ||
[[Category: Homo sapiens]] | [[Category: Homo sapiens]] | ||
[[Category: Non-specific protein-tyrosine kinase]] | [[Category: Non-specific protein-tyrosine kinase]] | ||
[[Category: Huang, X.]] | [[Category: Huang, X.]] | ||
[[Category: Atp-binding]] | [[Category: Atp-binding]] | ||
[[Category: Disease mutation]] | [[Category: Disease mutation]] | ||
[[Category: Host-virus interaction]] | [[Category: Host-virus interaction]] | ||
| Line 49: | Line 35: | ||
[[Category: Transferase]] | [[Category: Transferase]] | ||
[[Category: Tyrosine-protein kinase]] | [[Category: Tyrosine-protein kinase]] | ||
Revision as of 20:48, 25 July 2012
Crystal structure of pyrimidine amide 11 bound to Lck
Template:ABSTRACT PUBMED 18083554
About this Structure
3b2w is a 1 chain structure of Proto-oncogene tyrosine-protein kinase and Tyrosine kinase with sequence from Homo sapiens. Full crystallographic information is available from OCA.
See Also
Reference
- Deak HL, Newcomb JR, Nunes JJ, Boucher C, Cheng AC, DiMauro EF, Epstein LF, Gallant P, Hodous BL, Huang X, Lee JH, Patel VF, Schneider S, Turci SM, Zhu X. N-(3-(phenylcarbamoyl)arylpyrimidine)-5-carboxamides as potent and selective inhibitors of Lck: structure, synthesis and SAR. Bioorg Med Chem Lett. 2008 Feb 1;18(3):1172-6. Epub 2007 Dec 5. PMID:18083554 doi:https://dx.doi.org/10.1016/j.bmcl.2007.11.123